Document is current
Any future updates will be listed below
-
Authors
Wang, Siyu
Weissman, Drew https://orcid.org/0000-0002-1501-6510
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
- License Information
-
More Information
Article History
Accepted: 2 June 2025
First Online: 14 July 2025
Competing interests
: Y.D. is a scientific adviser for Arbor Biotechnologies. Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics. In accordance with the University of Pennsylvania policies and procedures and our ethical obligations as researchers, we report that D.W. is named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. S.W. declares no competing interests.
